Dysplastic features in 408 patients with AML
| Dysplastic lineages/parameter . | No. of cases (%) . | No. of cases . | MLD . | No. of cases (%) . | P for EFS . | P for OS . |
|---|---|---|---|---|---|---|
| No dysplasia | 132 (32.3) | No | 261 (64.0)* | .333 | .202 | |
| One dysplastic cell lineage | 129 (31.9) | No | ||||
| DysG | 34 | |||||
| DysE | 12 | |||||
| Dys M | 83 | |||||
| Two dysplastic cell lineages | 111 (30.0) | Yes | ||||
| DysG + DysE | 12 | 147 (36.0)† | ||||
| DysG + DysM | 79 | |||||
| DysE + DysM | 20 | |||||
| Trilineage dysplasia | 36 (8.8) | Yes | ||||
| Total | 408 (100) | 408 (100) |
| Dysplastic lineages/parameter . | No. of cases (%) . | No. of cases . | MLD . | No. of cases (%) . | P for EFS . | P for OS . |
|---|---|---|---|---|---|---|
| No dysplasia | 132 (32.3) | No | 261 (64.0)* | .333 | .202 | |
| One dysplastic cell lineage | 129 (31.9) | No | ||||
| DysG | 34 | |||||
| DysE | 12 | |||||
| Dys M | 83 | |||||
| Two dysplastic cell lineages | 111 (30.0) | Yes | ||||
| DysG + DysE | 12 | 147 (36.0)† | ||||
| DysG + DysM | 79 | |||||
| DysE + DysM | 20 | |||||
| Trilineage dysplasia | 36 (8.8) | Yes | ||||
| Total | 408 (100) | 408 (100) |